Jung Hyun Choi1, Sang Yeub Lee2, Yong Hyun Park3, Jae-Hyeong Park4, Kye Hun Kim5. 1. Division of Cardiology, Department of Internal Medicine, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Korea. 2. Division of Cardiology, Department of Internal Medicine, Chungbuk National University School of Medicine, Cheongju, Korea. 3. Division of Cardiology, Department of Internal Medicine, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Korea. 4. Department of Cardiology in Internal Medicine, Chungnam National University Hospital, Chungnam National University School of Medicine, Daejeon, Korea. 5. Department of Cardiology, Chonnam National University Hospital, Chonnam National University Medical School, Gwangju, Korea.
Abstract
Background and Objectives: Acute pulmonary embolism(PE) has high mortality and morbidity. Although reperfusion therapies can be used in high-risk PE patients, a few patients remain in a highly hemodynamically unstable state. In these patients, extracorporeal membrane oxygenation (ECMO) can be used to restore tissue oxygenation and improve their hemodynamic status. We retrospectively assessed the outcomes of ECMO in patients with high-risk PE. Methods: We retrospectively screened all acute PE patients from January 2010 to December 2019 in 5 university hospitals in Korea. We reviewed their medical records and clinical outcomes. Results: During the study period, we screened total 3,572 patients with PE and found 33 high-risk PE patients with ECMO (17 women, 58.3±14.7 years old) whose data were analyzed. Common causes of acute PE included limited mobility (8, 24.2%), a recent operation (6, 18.2%) and a recent hospitalization for medical diseases (3, 9.1%). Among the patients, 25 (75.0%) had a history of cardiopulmonary resuscitation. Nineteen patients had received primary therapy (intravenous thrombolysis in 10, thrombectomy in 8 and catheter-based thrombolysis in 1). The mean duration of ECMO was 5.0 days (range, 1-23 days). The in-hospital mortality rate was 51.5%. Twenty-two patients (66.7%) had ECMO related complications (15 [46.9%] had bleeding, 10 [31.3%] had an infection, and 5 [15.6%] had vascular complications). Of 15 cases with bleeding, 13 of them had mild bleeding associated with catheter insertion, and 2 had moderate multiorgan bleeding. Conclusions: ECMO can be used as an additional or alternative circulatory support method in high-risk PE patients. However, physicians should keep in mind a high incidence of complications related to ECMO.
Background and Objectives: Acute pulmonary embolism(PE) has high mortality and morbidity. Although reperfusion therapies can be used in high-risk PE patients, a few patients remain in a highly hemodynamically unstable state. In these patients, extracorporeal membrane oxygenation (ECMO) can be used to restore tissue oxygenation and improve their hemodynamic status. We retrospectively assessed the outcomes of ECMO in patients with high-risk PE. Methods: We retrospectively screened all acute PE patients from January 2010 to December 2019 in 5 university hospitals in Korea. We reviewed their medical records and clinical outcomes. Results: During the study period, we screened total 3,572 patients with PE and found 33 high-risk PE patients with ECMO (17 women, 58.3±14.7 years old) whose data were analyzed. Common causes of acute PE included limited mobility (8, 24.2%), a recent operation (6, 18.2%) and a recent hospitalization for medical diseases (3, 9.1%). Among the patients, 25 (75.0%) had a history of cardiopulmonary resuscitation. Nineteen patients had received primary therapy (intravenous thrombolysis in 10, thrombectomy in 8 and catheter-based thrombolysis in 1). The mean duration of ECMO was 5.0 days (range, 1-23 days). The in-hospital mortality rate was 51.5%. Twenty-two patients (66.7%) had ECMO related complications (15 [46.9%] had bleeding, 10 [31.3%] had an infection, and 5 [15.6%] had vascular complications). Of 15 cases with bleeding, 13 of them had mild bleeding associated with catheter insertion, and 2 had moderate multiorgan bleeding. Conclusions: ECMO can be used as an additional or alternative circulatory support method in high-risk PE patients. However, physicians should keep in mind a high incidence of complications related to ECMO.
Authors: Nicolas Meneveau; Benoit Guillon; Benjamin Planquette; Gaël Piton; Antoine Kimmoun; Lucie Gaide-Chevronnay; Nadia Aissaoui; Arthur Neuschwander; Elie Zogheib; Hervé Dupont; Sebastien Pili-Floury; Fiona Ecarnot; François Schiele; Nicolas Deye; Nicolas de Prost; Raphaël Favory; Philippe Girard; Mircea Cristinar; Alexis Ferré; Guy Meyer; Gilles Capellier; Olivier Sanchez Journal: Eur Heart J Date: 2018-12-14 Impact factor: 29.983
Authors: Stavros V Konstantinides; Adam Torbicki; Giancarlo Agnelli; Nicolas Danchin; David Fitzmaurice; Nazzareno Galiè; J Simon R Gibbs; Menno V Huisman; Marc Humbert; Nils Kucher; Irene Lang; Mareike Lankeit; John Lekakis; Christoph Maack; Eckhard Mayer; Nicolas Meneveau; Arnaud Perrier; Piotr Pruszczyk; Lars H Rasmussen; Thomas H Schindler; Pavel Svitil; Anton Vonk Noordegraaf; Jose Luis Zamorano; Maurizio Zompatori Journal: Eur Heart J Date: 2014-08-29 Impact factor: 29.983
Authors: Stavros V Konstantinides; Guy Meyer; Cecilia Becattini; Héctor Bueno; Geert-Jan Geersing; Veli-Pekka Harjola; Menno V Huisman; Marc Humbert; Catriona Sian Jennings; David Jiménez; Nils Kucher; Irene Marthe Lang; Mareike Lankeit; Roberto Lorusso; Lucia Mazzolai; Nicolas Meneveau; Fionnuala Ní Áinle; Paolo Prandoni; Piotr Pruszczyk; Marc Righini; Adam Torbicki; Eric Van Belle; José Luis Zamorano Journal: Eur Heart J Date: 2020-01-21 Impact factor: 35.855